Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial

BACKGROUND: Bisphosphonates are the standard of care for reducing the risk of skeletal-related events in patients with bone lesions from multiple myeloma. The MRC Myeloma IX study was designed to compare the effects of zoledronic acid versus clodronic acid in newly diagnosed patients with multiple m...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Morgan, Gareth J, Child, J Anthony, Gregory, Walter M, Szubert, Alex J, Cocks, Kim, Bell, Sue E, Navarro-Coy, Nuria, Drayson, Mark T, Owen, Roger G, Feyler, Sylvia, Ashcroft, A John, Ross, Fiona M, Byrne, Jennifer, Roddie, Huw, Rudin, Claudius, Cook, Gordon, Jackson, Graham H, Wu, Ping, Davies, Faith E
Format: Artigo
Sprog:Inglês
Udgivet: Lancet Pub. Group 2011
Fag:
Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3148431/
https://ncbi.nlm.nih.gov/pubmed/21771568
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(11)70157-7
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker